ReproCELL Incorporated (TYO:4978)

Market Cap	11.59B -26.2%
Revenue (ttm)	2.23B -25.0%
Net Income	-591.00M
EPS	-6.24
Shares Out	95.03M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	430,500
Open	122.00
Previous Close	122.00
Day's Range	119.00 - 122.00
52-Week Range	119.00 - 242.00
Beta	0.55
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About ReproCELL

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 99
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4978

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 24, 2026

Data Sources Report a data error